GeneDx CEO on a Mission: Ending the 'Diagnostic Odyssey' for Rare Diseases
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.